Total Holdings
82
Portfolio diversification across 82 positions
AGNG
(NASDAQ)Global X Aging Population ETF
$38.30-- (--)
Loading... - Market loading
AGNG ETF Holdings: Global X Aging Population ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$84.82M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Fund Issuer
Global X
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | E EBR:UCB | UCB SA | Stock | 4.58% |
| 2 |  | Johnson & Johnson | Stock | 3.67% |
| 3 | S SWX:RO | Roche Holding AG | Stock | 3.54% |
| 4 |  | Merck & Co., Inc. | Stock | 3.52% |
| 5 |  | Eli Lilly and Company | Stock | 3.41% |
| 6 | L LON:AZN | AstraZeneca PLC | Stock | 3.34% |
| 7 |  | AstraZeneca PLC | Stock | 3.33% |
| 8 |  | Welltower Inc | Stock | 3.29% |
| 9 |  | Regeneron Pharmaceuticals, Inc | Stock | 3.21% |
| 10 |  | AbbVie Inc | Stock | 3.06% |
| 11 |  | Amgen Inc. | Stock | 3.05% |
| 12 | T TYO:4519 | Chugai Pharmaceutical Co., Ltd. | Stock | 3.04% |
| 13 |  | Edwards Lifesciences Corporation | Stock | 2.98% |
| 14 | T TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 2.97% |
| 15 |  | Medtronic plc | Stock | 2.94% |
| 16 |  | Bristol-Myers Squibb Company | Stock | 2.60% |
| 17 |  | Stryker Corporation | Stock | 2.53% |
| 18 |  | Boston Scientific Corporation | Stock | 2.46% |
| 19 |  | Ventas, Inc | Stock | 2.40% |
| 20 | S SWX:SDZ | Sandoz Group AG | Stock | 2.35% |
| 21 |  | BeOne Medicines AG | Stock | 2.32% |
| 22 | H HKG:3692 | Hansoh Pharmaceutical Group Co Ltd | Stock | 2.31% |
| 23 | S SWX:ALC | Alcon AG | Stock | 2.23% |
| 24 | B BGNE | BeiGene, Ltd | Stock | 2.21% |
| 25 | K KRX:068270 | Celltrion, Inc. | Stock | 2.21% |
| 26 | K KO:068270 | Celltrion Inc | Stock | 1.97% |
| 27 | L LSE:0QIU | Novo Nordisk A/S Class B | Stock | 1.92% |
| 28 | T TYO:4503 | Astellas Pharma Inc. | Stock | 1.90% |
| 29 |  | DexCom, Inc. | Stock | 1.86% |
| 30 | T TSE:4503 | Astellas Pharma Inc. | Stock | 1.69% |
| 31 | C CPH:NOVO.B | Novo Nordisk A/S | Stock | 1.62% |
| 32 |  | United Therapeutics Corporation | Stock | 1.56% |
| 33 | T TSE:4543 | Terumo Corp. | Stock | 1.55% |
| 34 |  | Insulet Corporation | Stock | 1.46% |
| 35 | S SWX:STMN | Straumann Holding AG | Stock | 1.35% |
| 36 |  | Exact Sciences Corporation | Stock | 1.33% |
| 37 |  | Incyte Corporation | Stock | 1.30% |
| 38 |  | Zimmer Biomet Holdings, Inc | Stock | 1.28% |
| 39 |  | Neurocrine Biosciences, Inc | Stock | 1.07% |
| 40 | S SWX:SOON | Sonova H Ag | Stock | 1.06% |
| 41 | L LSE:SN | Smith & Nephew PLC | Stock | 1.00% |
| 42 | E ETR:FME | Fresenius Medical Care AG & Co. KGaA | Stock | 0.98% |
| 43 |  | Omega Healthcare Investors, Inc | Stock | 0.87% |
| 44 | A ASX:COH | Cochlear Ltd | Stock | 0.81% |
| 45 |  | Exelixis, Inc | Stock | 0.80% |
| 46 |  | The Ensign Group, Inc | Stock | 0.71% |
| 47 |  | DaVita Inc | Stock | 0.68% |
| 48 |  | CG Oncology, Inc. Common stock | Stock | 0.63% |
| 49 |  | Halozyme Therapeutics, Inc | Stock | 0.54% |
| 50 |  | Theravance Biopharma Inc | Stock | 0.53% |